SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Mama Bear who wrote (972)12/14/1997 3:00:00 PM
From: Claud B  Read Replies (1) | Respond to of 7041
 
Barbara,

Would you tell that to IBM, MO, PD,etc.??
They are always buying back their stock when they think
"it's the best investment they can make."

And somehow, they still manage to run their company pretty well.

Claud



To: Mama Bear who wrote (972)12/14/1997 5:09:00 PM
From: BigKNY3  Read Replies (2) | Respond to of 7041
 
Barbara <<In case anyone is wondering, I usually pay special attention to Asensio's short picks. He is really good at identifying the companies that should be shorted.>>

Barb: Asensio states in his reports "our only asset is the correctness and completeness of our research". Since October 18, 1997, in two separate Zongaen reports Asensio has never once mentioned the Schering /Zonagen agreement concerning Vasomax.

Do you agree that although he may be good at identifying companies to short, his credibility and "asset" is worthless?

BigKNY3